Bhatia Manohar, Sharma Yogesh, Dwivedi Vikas, Sukla Pradeep, Mitra Bikramjeet, Pandey Vikas, Rai Varsha
Community Medicine, Government Medical College, Datia, Datia, IND.
Community Medicine, World Health Organization Regional Office, Bhopal, IND.
Cureus. 2025 May 23;17(5):e84663. doi: 10.7759/cureus.84663. eCollection 2025 May.
Tuberculosis (TB) remains a significant public health challenge in India, particularly in Madhya Pradesh. In this study, we aimed to examine epidemiological trends and treatment outcomes in TB patients in the Datia and Tikamgarh districts of Madhya Pradesh, from 2018 to 2022, to inform targeted TB control strategies.
We conducted a retrospective observational study using data from the National TB Elimination Program (NTEP), accessed through the Nikshay portal (a Government of India initiative). We analyzed trends in TB notifications, rates of microbiological confirmation, treatment outcomes, and co-infections. Statistical tests, including the Mann-Whitney U test, Kruskal-Wallis test, and chi-square test, were employed, with a p-value of less than 0.05 indicating statistical significance.
In Datia, the proportion of pediatric TB cases decreased from 6% to 3% (p = 0.04), while extrapulmonary TB (EPTB) cases rose from 11.3% to 13.8% (p = 0.02). Notifications from the private sector significantly increased from 4% to 28% (p = 0.03), whereas drug-resistant TB (DR-TB) cases fell from 2% to 1% (p = 0.02). TB-related mortality rose from 3.28% to 3.93% (p = 0.008), with the proportion of patients lost to follow-up remaining stable at 9%-10% (p = 0.02). In Tikamgarh, pediatric TB rates declined from 7.7% to 6.3% (p = 0.04), and EPTB cases increased from 4.77% to 9.37% (p = 0.02). Notifications from the private sector surged from 1.13% to 20.75% (p = 0.03). DR-TB rates decreased from 4.33% to 1% (p = 0.02), but TB-related mortality increased from 1.87% to 5.46% (p = 0.008). The rate of patients lost to follow-up improved slightly, decreasing from 12.71% to 10.09% (p = 0.02).
The reduction in pediatric TB and DR-TB indicates progress in diagnosis and treatment adherence. However, the rising incidence of EPTB and increasing mortality rates highlight ongoing challenges. Enhancing private sector involvement, improving patient adherence, and integrating HIV-TB care are crucial for achieving India's TB elimination objectives.
结核病在印度仍然是一项重大的公共卫生挑战,在中央邦尤为如此。在本研究中,我们旨在调查2018年至2022年中央邦达蒂亚和蒂卡姆加尔地区结核病患者的流行病学趋势及治疗结果,以为针对性的结核病控制策略提供依据。
我们进行了一项回顾性观察研究,使用通过Nikshay门户网站(印度政府的一项举措)获取的国家结核病消除计划(NTEP)的数据。我们分析了结核病通报趋势、微生物确诊率、治疗结果及合并感染情况。采用了包括曼-惠特尼U检验、克鲁斯卡尔-沃利斯检验和卡方检验在内的统计检验,p值小于0.05表示具有统计学意义。
在达蒂亚,儿童结核病病例的比例从6%降至3%(p = 0.04),而肺外结核病(EPTB)病例从11.3%升至13.8%(p = 0.02)。私营部门的通报显著增加,从4%增至28%(p = 0.03),而耐多药结核病(DR-TB)病例从2%降至1%(p = 0.02)。结核病相关死亡率从3.28%升至3.93%(p = 0.008),失访患者的比例保持稳定,为9%-10%(p = 0.02)。在蒂卡姆加尔,儿童结核病发病率从7.7%降至6.3%(p = 0.04),EPTB病例从4.77%增至9.37%(p = 0.02)。私营部门的通报从1.13%激增至20.75%(p = 0.03)。DR-TB发病率从4.33%降至1%(p = 0.02),但结核病相关死亡率从1.87%增至5.46%(p = 0.008)。失访患者的比例略有改善,从12.71%降至10.09%(p = 0.02)。
儿童结核病和DR-TB的减少表明在诊断和治疗依从性方面取得了进展。然而,EPTB发病率的上升和死亡率的增加凸显了持续存在的挑战。加强私营部门的参与、提高患者依从性以及整合艾滋病毒-结核病护理对于实现印度的结核病消除目标至关重要。